Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
Claus Garbe(University of Tübingen), David C. Whiteman(Queensland Health), Ulrike Keim, Bernd Hollezcek(Krebsregister Saarland), Peter Martus(University of Tübingen), Teresa Amaral(University Children's Hospital Tübingen), Alexander Katalinic(Independent Centre for Privacy Protection), Ulrike Leiter(University of Tübingen), Lukas Flatz(Leman University), Sara Gandini(European Institute of Oncology)
Cited by 150
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
|JAMA Dermatology|2022|1.4k